Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene

被引:1
|
作者
Komvilaisak, Patcharee [1 ]
Yudhasompop, Najwa [2 ]
Kanchanakamhaeng, Kittima [3 ]
Hongeng, Suradej [4 ]
Pakakasama, Samart [4 ]
Anurathapan, Usanarat [4 ]
Pongphitcha, Pongpak [4 ]
Songdej, Duantida [4 ]
Sasanakul, Werasak [4 ]
Sirachainan, Nongnuch [4 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand
[2] Hatyai Hosp, Dept Radiol, Songkhla, Thailand
[3] Sawanpracharak Hosp, Dept Pediat, Nakhon Sawan, Thailand
[4] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Fac Med, 270 Rama VI Rd, Bangkok 10400, Thailand
关键词
Severe congenital neutropenia; Cyclic neutropenia; ELANE Gene; SEVERE CONGENITAL NEUTROPENIA; MYELOID-LEUKEMIA; DIAGNOSIS; ELASTASE;
D O I
10.1186/s12887-023-04428-w
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Congenital neutropenia is a rare disease. Recurrent infections since young age are the presentation. The most common mutation causing severe congenital neutropenia (SCN) and cyclic neutropenia (CyN) is the ELANE gene. The objectives of this study were to screen the three common genetic mutations of ELANE, HAX1 and GFI1 in children with chronic neutropenia and to describe the clinical characteristics of children who had the mutations. Methods Infants having ANC < 1,000/cu mm or children aged > 1 year having ANC < 1,500/cu mm at least 3 times in 3 months were enrolled in the study. Patients who had acquired neutropenia due to infection, immune deficiency, or drugs were excluded. The ELANE gene was first studied; and if mutations were not identified, the HAX1 and GFI1 genes were further examined. Results A total of 60 patients were enrolled in the study. The median (range) age, ratio of female to male, ANC, and last follow-up age were 9.2 (0.5-45.2) months, 1:1.2, 248 (0-1,101) /cu mm, and 19.9 (3.5-202.3) months, respectively. Infections were noted in 67.3% of all patients. ELANE gene mutation was found in only four patients (6.7%), and the rest (56 patients) showed no mutations in the HAX1 and GFI1 genes. In patients without mutations, 66.0% had normal ANC during the follow-up, with a median (range) age for normal ANC of 19.8 (4.0-60.0) months. Two novel mutations p. Ala79del (c.234_236del) and p. Val197GlufsTer18 (c.589_590insAGGCCGGC) were identified, and they respectively cause SCN and CyN. Patients with the two novel mutations presented with several episodes of infection, including pneumonia, sepsis, abscess, otitis media, and gum infection. Conclusion The genetic screening for ELANE, HAX1, and GFI1 gene mutations in 60 patients with chronic neutropenia could identify four patients (6.7%) with ELANE gene mutation and two novel mutations, p. Ala79del in exon 3 and p. Val197GlufsTer18 in exon 4 causing SCN; and CyN, respectively.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations
    Muhammad Faiyaz-Ul-Haque
    Abdullah Al-Jefri
    Fouad Al-Dayel
    Jalaluddin A. K. M. Bhuiyan
    Hala A. Abalkhail
    Randa Al-Nounou
    Ahmed Al-Abdullatif
    Monogaran S. Pulicat
    Ameera Gaafar
    Ayodele A. Alaiya
    Iskra Peltekova
    Syed H. E. Zaidi
    European Journal of Pediatrics, 2010, 169 : 661 - 666
  • [22] A novel missense mutation in the HAX1 gene in severe congenital neutropenia patients (Kostmann disease)
    Faiyaz-Ul-Haquea, M.
    Al-Jefric, A.
    Abalkhail, H. A.
    Toulimat, M.
    Al-Muallimi, M. A.
    Pulicat, M. S.
    Gaafar, A.
    Alaiya, A. A.
    Al-Dayel, F.
    Peltekova, I.
    Zaidi, S. H. E.
    CLINICAL GENETICS, 2009, 76 (06) : 569 - 572
  • [23] A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations
    Faiyaz-Ul-Haque, Muhammad
    Al-Jefri, Abdullah
    Al-Dayel, Fouad
    Bhuiyan, Jalaluddin A. K. M.
    Abalkhail, Hala A.
    Al-Nounou, Randa
    Al-Abdullatif, Ahmed
    Pulicat, Monogaran S.
    Gaafar, Ameera
    Alaiya, Ayodele A.
    Peltekova, Iskra
    Zaidi, Syed H. E.
    EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (06) : 661 - 666
  • [24] Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds
    Smith, Bradley N.
    Ancliff, Phil J.
    Pizzey, Arnold
    Khwaja, Asim
    Linch, David C.
    Gale, Rosemary E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (05) : 762 - 770
  • [25] Identification of two novel homozygous HAX1 mutations in an autosomal recessive Jewish and two unrelated sporadic British families with severe congenital neutropenia
    Smith, Bradley N.
    Ancliff, Phil J.
    Linch, David C.
    Gale, Rosemary E.
    BLOOD, 2007, 110 (11) : 972A - 972A
  • [26] Mutations in the TNFRSF1A, CEBPE and ELANE genes in a Congenital Cyclic Neutropenia Patient: A New Syndrome?
    Skokowa, Julia
    Klimenkova, Olga
    Klimiankou, Maksim
    Kandabarau, Siarhei
    Reuter, Marlene
    Hagemann, Anna-Lena
    Welte, Karl
    BLOOD, 2012, 120 (21)
  • [27] Compound Heterozygous HAX1 Mutations in a Swedish Patient With Severe Congenital Neutropenia and No Neurodevelopmental Abnormalities
    Carlsson, Goran
    Elinder, Goran
    Malmgren, Helena
    Trebinska, Alicja
    Grzybowska, Ewa
    Dahl, Niklas
    Nordenskjold, Magnus
    Fadeel, Bengt
    PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 1143 - 1146
  • [28] A comparison of different strategies for CRISPR/Cas9-based gene therapies of congenital neutropenia associated with ELANE mutations
    Ritter, M. U.
    Nasri, M.
    Dannenmann, B.
    Mir, P.
    Secker, B.
    Zeidler, C.
    Klimiankou, M.
    Welte, K.
    Skokowa, J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A175 - A175
  • [29] UPDATE On the RISK of SECONDARY LEUKEMIA In GENETIC SUBGROUPS (ELANE, HAX1, WAS, G6PC3, p14) of CONGENITAL NEUTROPENIA In EUROPE
    Zeidler, Cornelia
    Vandenberghe, Peter
    Schaefer, Irina
    Hoy, Ludwig
    Zimmermann, Martin
    Germeshausen, Manuela
    Welte, Karl
    BLOOD, 2011, 118 (21) : 507 - 507
  • [30] Efficient Correction of HAX1 Mutations in Primary HSPCs of Severe Congenital Neutropenia Patients Using CRISPR/CAS9 GENE-Editing
    Ritter, Malte U.
    Secker, Benjamin
    Nasri, Masoud
    Klimiankou, Maksim
    Dannenmann, Benjamin
    Amend, Diana
    Haaf, Jeremy
    Mir, Perihan
    Bernhard, Regine
    Steiert, Ingeborg
    Zeidler, Cornelia
    Welte, Karl
    Skokowa, Julia
    BLOOD, 2020, 136